Curis
CRIS
#10557
Rank
C$24.52 M
Marketcap
C$0.63
Share price
37.69%
Change (1 day)
-80.06%
Change (1 year)

Earnings for Curis (CRIS)

Earnings in 2025 (TTM): -C$45.86 Million

According to Curis's latest financial reports the company's current earnings are C$11.65 Million. In 2024 the company made an earning of -C$60.9 Million, an increase over its 2023 earnings that were of -C$64.63 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Curis from 2001 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -C$45.86 Million-24.7%
2024 -C$60.9 Million-5.77%
2023 -C$64.63 Million-13.1%
2022 -C$74.37 Million27.52%
2021 -C$58.32 Million65.09%
2020 -C$35.33 Million-9.1%
2019 -C$38.86 Million-4.73%
2018 -C$40.79 Million-41.95%
2017 -C$70.26 Million-14.37%
2016 -C$82.05 Million3.55%
2015 -C$79.24 Million271.52%
2014 -C$21.33 Million76.64%
2013 -C$12.08 Million
2011 -C$10.26 Million27.76%
2010 -C$8.03 Million-43.87%
2009 -C$14.31 Million-23.44%
2008 -C$18.68 Million56.66%
2007 -C$11.93 Million-16.71%
2006 -C$14.32 Million-36.92%
2005 -C$22.7 Million156.25%
2004 -C$8.86 Million-37.24%
2003 -C$14.12 Million-93.34%
2002 -C$0.22 Billion86.79%
2001 -C$0.12 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
C$15.07 B-32,629.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
C$13.66 B-29,576.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
-C$88.1 Million 90.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Exelixis
EXEL
C$1.42 B-3,181.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-C$0.41 Billion 782.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
-C$35.26 Million-23.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
C$0.23 B-607.71%๐Ÿ‡บ๐Ÿ‡ธ USA